- Home
- TELO vs ANVS Comparison
TELO vs ANVS Comparison
Compare TELO & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELO
- ANVS
- Stock Information
- Founded
- TELO 2021
- ANVS 2008
- Country
- TELO United States
- ANVS United States
- Employees
- TELO N/A
- ANVS N/A
- Industry
- TELO
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- TELO
- ANVS Health Care
- Exchange
- TELO NYSE
- ANVS Nasdaq
- Market Cap
- TELO 124.1M
- ANVS 110.4M
- IPO Year
- TELO 2024
- ANVS 2020
- Fundamental
- Price
- TELO $3.73
- ANVS $6.85
- Analyst Decision
- TELO
- ANVS Strong Buy
- Analyst Count
- TELO 0
- ANVS 6
- Target Price
- TELO N/A
- ANVS $29.67
- AVG Volume (30 Days)
- TELO 61.7K
- ANVS 261.0K
- Earning Date
- TELO 11-12-2024
- ANVS 11-08-2024
- Dividend Yield
- TELO N/A
- ANVS N/A
- EPS Growth
- TELO N/A
- ANVS N/A
- EPS
- TELO N/A
- ANVS N/A
- Revenue
- TELO N/A
- ANVS N/A
- Revenue This Year
- TELO N/A
- ANVS N/A
- Revenue Next Year
- TELO N/A
- ANVS N/A
- P/E Ratio
- TELO N/A
- ANVS N/A
- Revenue Growth
- TELO N/A
- ANVS N/A
- 52 Week Low
- TELO $3.11
- ANVS $4.53
- 52 Week High
- TELO $20.72
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- TELO 35.99
- ANVS 30.84
- Support Level
- TELO $4.11
- ANVS $7.30
- Resistance Level
- TELO $4.54
- ANVS $8.93
- Average True Range (ATR)
- TELO 0.33
- ANVS 0.56
- MACD
- TELO -0.01
- ANVS -0.26
- Stochastic Oscillator
- TELO 5.36
- ANVS 4.89
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.